Proficio Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,275
| Closed | -$474K | – | 305 |
|
|
2025
Q2 | $474K | Buy |
4,275
+232
| +6% | +$24.7K | 0.03% | 256 |
|
|
2025
Q1 | $453K | Buy |
4,043
+368
| +10% | +$38K | 0.04% | 226 |
|
|
2024
Q4 | $339K | Buy |
+3,675
| New | +$331K | 0.03% | 247 |
|
|
2024
Q2 | – | Sell |
-3,168
| Closed | -$232K | – | 329 |
|
|
2024
Q1 | $232K | Buy |
3,168
+74
| +2% | +$5.69K | 0.03% | 290 |
|
|
2023
Q4 | $251K | Buy |
3,094
+329
| +12% | +$25.6K | 0.03% | 258 |
|
|
2023
Q3 | $207K | Buy |
+2,765
| New | +$213K | 0.03% | 279 |
|
|
2023
Q2 | – | Sell |
-2,491
| Closed | -$207K | – | 302 |
|
|
2023
Q1 | $207K | Buy |
2,491
+91
| +4% | +$7.54K | 0.03% | 272 |
|
|
2022
Q4 | $210K | Buy |
+2,400
| New | +$190K | 0.04% | 261 |
|
|
2022
Q1 | – | Sell |
-2,861
| Closed | -$208K | – | 304 |
|
|
2021
Q4 | $208K | Buy |
+2,861
| New | +$197K | 0.03% | 286 |
|
|
2021
Q3 | – | Sell |
-3,318
| Closed | -$228K | – | 312 |
|
|
2021
Q2 | $228K | Buy |
3,318
+96
| +3% | +$6.41K | 0.03% | 264 |
|
|
2021
Q1 | $208K | Buy |
+3,222
| New | +$208K | 0.03% | 256 |
|
|
2020
Q3 | – | Sell |
-3,816
| Closed | -$294K | – | 180 |
|
|
2020
Q2 | $294K | Buy |
3,816
+311
| +9% | +$23.8K | 0.06% | 129 |
|
|
2020
Q1 | $269K | Buy |
+3,505
| New | +$242K | 0.07% | 121 |
|
|
2019
Q3 | – | Sell |
-1,489
| Closed | -$101K | – | 684 |
|
|
2019
Q2 | $101K | Buy |
1,489
+1,065
| +251% | +$70.1K | 0.03% | 207 |
|
|
2019
Q1 | $28K | Sell |
424
-548
| -56% | -$36.4K | 0.01% | 524 |
|
|
2018
Q4 | $61K | Sell |
972
-22
| -2% | -$1.54K | 0.03% | 246 |
|
|
2018
Q3 | $77K | Buy |
994
+258
| +35% | +$19.5K | 0.03% | 255 |
|
|
2018
Q2 | $52K | Sell |
736
-393
| -35% | -$27.8K | 0.02% | 345 |
|
|
2018
Q1 | $85K | Buy |
1,129
+53
| +5% | +$4.21K | 0.03% | 240 |
|
|
2017
Q4 | $77K | Buy |
1,076
+74
| +7% | +$5.62K | 0.02% | 261 |
|
|
2017
Q3 | $81K | Buy |
1,002
+453
| +83% | +$34.6K | 0.03% | 279 |
|
|
2017
Q2 | $42K | Sell |
549
-332
| -38% | -$22.1K | 0.02% | 421 |
|
|
2017
Q1 | $57K | Buy |
881
+637
| +261% | +$44.8K | 0.02% | 352 |
|
|
2016
Q4 | $17K | Sell |
244
-6
| -2% | -$446 | 0.01% | 494 |
|
|
2016
Q3 | $20K | Sell |
250
-121
| -33% | -$9.83K | 0.01% | 425 |
|
|
2016
Q2 | $30K | Buy |
371
+100
| +37% | +$8.88K | 0.02% | 360 |
|
|
2016
Q1 | $25K | Buy |
271
+14
| +5% | +$1.26K | 0.02% | 308 |
|
|
2015
Q4 | $26K | Buy |
+257
| New | +$26.7K | 0.03% | 163 |
|
Other funds holding GILD
Proficio Capital Partners's GILD Position: Q3 2025 in Review
Proficio Capital Partners sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 4,275 shares — an estimated $474K sold.
Proficio Capital Partners first reported a position in GILD in Q4 2015 and held it in 28 quarters. The position peaked at $474K in Q2 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Proficio Capital Partners reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Proficio Capital Partners sold 4,275 Gilead Sciences shares in Q3 2025, an estimated $474K.
- Proficio Capital Partners first reported a position in Gilead Sciences in Q4 2015 and held it in 28 quarters.
- Proficio Capital Partners's Gilead Sciences position peaked at $474K in Q2 2025.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Proficio Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.